MarketPulse

rheumatoid arthritis

4 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

RA Drug Pipeline Accelerates: 75+ Companies Race to Launch 80+ Therapies

DelveInsight's 2026 report shows robust rheumatoid arthritis pipeline with 75+ players developing 80+ drugs, featuring novel JAK and BTK inhibitors plus cell-based therapies.
BMYCELGrABBVLLYNVS+4clinical trialsdrug development
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Artiva Biotherapeutics to Present Cell Therapy Pipeline at Needham Healthcare Conference

Artiva Biotherapeutics to present AlloNK cell therapy pipeline at Needham Healthcare Conference on April 15, 2026, advancing three ongoing autoimmune disease trials.
ARTVclinical trialsautoimmune diseases
GlobeNewswire Inc.GlobeNewswire Inc.··Jade Biosciences, Inc.

Jade Biosciences Posts $127.4M Loss, Eyes 2028 Cash Runway With Pipeline Catalysts

Jade Biosciences reports $127.4M full-year loss, maintains $336.2M cash runway through mid-2028 with pipeline data catalysts starting Q2 2026.
JBIOmonoclonal antibodyclinical trials
GlobeNewswire Inc.GlobeNewswire Inc.··Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics Names Veteran Pharma Executive Huston as CFO

Artiva Biotherapeutics appoints veteran pharma executive Thad Huston as CFO with 30+ years experience, ahead of key FDA feedback and clinical data milestones.
ARTVrestricted stock unitsautoimmune diseases